Compass Therapeutics, Inc.

NASDAQ:CMPX

1.73 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q2
Omzet 02.8440000000000000000000000
Kosten van de omzet 0.4630.4680.4660.4750.4810.4840.4870.4980.4350.3960.4060.4090.41300000000000
Brutowinst -0.4632.376-0.466-0.475-0.481-0.484-0.487-0.498-0.435-0.396-0.406-0.409-0.41300000000000
Brutowinstmarge 00.8350000000000000000000000
Onderzoek- en ontwikkelingskosten 9.36812.2658.83110.2236.6389.9289.7915.8624.4159.5743.1542.9054.7044.4063.672.9853.5713.3035.9795.3897.243000
Algemene en administratieve kosten 3.2482.9673.0953.1143.0732.962.8073.1252.7673.4272.72.1662.6353.5445.2912.0852.263.0992.4043.2843.351000
Verkoop- en marketingkosten -0.309-0.3070000000000000000000000
Verkoop-, algemene en administratieve kosten 2.9392.663.0953.1143.0732.962.8073.1252.7673.4272.72.1662.6353.5445.2912.0852.263.0992.4043.2843.351000
Overige kosten 1.983-1.874001.874000050.618-0.04450.6180-18.42-8.9520-2.2280000000
Bedrijfskosten 12.30714.92511.92613.3379.71112.88812.5988.9877.18213.0015.8545.0717.3397.958.9615.075.8316.4028.3838.67310.658000
Bedrijfsresultaat -12.77-15.393-11.926-13.337-9.711-12.888-12.598-8.987-7.182-13.001-5.854-55.689-7.339-7.95-8.961-5.07-5.831-6.402-8.383-8.673-10.594000
Bedrijfsresultaat ratio 0-5.4120000000000000000000000
Totaal overige inkomsten en kosten netto 1.9831.9781.9622.0591.8741.2940.6230.4930.020.042-0.044-50.6180.044-0.2810.001-0.236-0.32-0.012-0.007-0.033-0.148000
Inkomen voor belasting -10.787-13.415-9.964-11.278-7.837-11.594-11.975-8.494-7.162-12.994-5.975-55.791-7.422-8.391-9.15-5.541-6.386-6.602-8.526-8.783-10.742000
Inkomen voor belasting ratio 0-4.7170000000000000000000000
Belastingkosten 0.421.8740.5060.353-1.874-1.294-0.623-0.493-0.02-0.0130.0340.0130.1420.1780.2120.0160.0160.010.0260.0260.029000
Nettowinst -10.787-13.415-9.964-11.278-5.963-10.3-11.352-8.001-7.142-12.981-5.975-55.804-7.422-8.391-9.15-5.557-6.402-6.612-8.552-8.809-10.771000
Nettowinstmarge 0-4.7170000000000000000000000
WPA (Winst Per Aandeel) -0.079-0.11-0.078-0.089-0.047-0.098-0.11-0.079-0.071-0.25-0.097-1.07-0.14-0.14-0.15-0.11-0.12-0.11-0.16-0.17-2.15000
Verwaterde WPA -0.079-0.11-0.078-0.089-0.047-0.098-0.11-0.079-0.071-0.25-0.097-1.07-0.14-0.14-0.15-0.11-0.12-0.11-0.16-0.17-2.15000
EBITDA -12.307-14.925-11.46-12.862-9.23-11.11-11.488-8.065-6.727-12.601-5.491-4.653-6.911-6.863-8.504-4.626-5.327-5.785-7.668-8.436-10.068000
EBITDA ratio 0-5.2480000000000000000000000